NNOX Stock Overview
Develops a commercial-grade tomographic imaging device with a digital X-ray source.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Nano-X Imaging Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$8.11 |
52 Week High | US$22.69 |
52 Week Low | US$4.89 |
Beta | 2.14 |
1 Month Change | -13.22% |
3 Month Change | -18.98% |
1 Year Change | -59.49% |
3 Year Change | -71.66% |
5 Year Change | n/a |
Change since IPO | -62.63% |
Recent News & Updates
Is Nano-X Imaging (NASDAQ:NNOX) Weighed On By Its Debt Load?
Apr 05Nano-X Imaging: System Deployments Finally Begin
Apr 01Recent updates
Is Nano-X Imaging (NASDAQ:NNOX) Weighed On By Its Debt Load?
Apr 05Nano-X Imaging: System Deployments Finally Begin
Apr 01Nano-X Imaging gains on FDA submission for new digital X-ray technology
Sep 28Nano-X Imaging Q2 Earnings Preview
Aug 15Nano-X: Too Controversial To Buy
Jun 30Nano-X Imaging Q4 2021 Earnings Preview: Insight Coming Regarding This Binary Play
Mar 30Monday's Drop Isn't Likely The Last One For Nano-X
Dec 28Nano-X Imaging Stock Is A No-No Buy
Oct 11We're Interested To See How Nano-X Imaging (NASDAQ:NNOX) Uses Its Cash Hoard To Grow
Aug 20Nanox submits 510(k) application for first version of Nanox.ARC 3-D in U.S.
Jun 17We're Not Worried About Nano-X Imaging's (NASDAQ:NNOX) Cash Burn
May 05Here's What Nano-X Imaging Ltd.'s (NASDAQ:NNOX) Shareholder Ownership Structure Looks Like
Mar 08Nano-X Imaging lower 10% on additional information request by FDA on Nanox.ARC version
Feb 01Nano-X Imaging (NASDAQ:NNOX) Is In A Strong Position To Grow Its Business
Jan 13Nano-X Imaging and USARAD extend strategic collaboration
Jan 05Nano-X Vision Under The X-Ray
Dec 09What Type Of Shareholders Make Up Nano-X Imaging Ltd.'s (NASDAQ:NNOX) Share Registry?
Nov 21Nano-X Imaging EPS misses by $0.12
Nov 09NANO-X Imaging: Novel Technology Or Outdated Technology?
Nov 02Shareholder Returns
NNOX | US Healthcare | US Market | |
---|---|---|---|
7D | -3.8% | 0.6% | -0.6% |
1Y | -59.5% | 1.6% | 22.4% |
Return vs Industry: NNOX underperformed the US Healthcare industry which returned 1.3% over the past year.
Return vs Market: NNOX underperformed the US Market which returned 22.5% over the past year.
Price Volatility
NNOX volatility | |
---|---|
NNOX Average Weekly Movement | 9.3% |
Healthcare Industry Average Movement | 6.4% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: NNOX's share price has been volatile over the past 3 months.
Volatility Over Time: NNOX's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 164 | Erez Meltzer | www.nanox.vision |
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Nano-X Imaging Ltd. Fundamentals Summary
NNOX fundamental statistics | |
---|---|
Market cap | US$483.11m |
Earnings (TTM) | -US$61.26m |
Revenue (TTM) | US$10.01m |
46.8x
P/S Ratio-7.7x
P/E RatioIs NNOX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NNOX income statement (TTM) | |
---|---|
Revenue | US$10.01m |
Cost of Revenue | US$17.13m |
Gross Profit | -US$7.12m |
Other Expenses | US$54.13m |
Earnings | -US$61.26m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.06 |
Gross Margin | -71.15% |
Net Profit Margin | -611.89% |
Debt/Equity Ratio | 1.8% |
How did NNOX perform over the long term?
See historical performance and comparison